Literature DB >> 21170613

How should allergists deal with local reactions to allergen immunotherapy?

Michael S Tankersley1.   

Abstract

Despite the well-known benefits of subcutaneous immunotherapy (SCIT), adverse reactions include both local reactions (LRs) and systemic reactions. An LR is a well-known adverse event associated with SCIT injections and is defined as any swelling located at or near the injection site following allergen injection. Concerns that LRs might predict systemic reactions have historically motivated allergists to dose adjust for LRs. More recent data have dispelled this notion, although many allergists continue to dose adjust for other reasons. This article discusses the historical response to LRs and dose adjustments and reviews the most recent literature addressing LRs to SCIT. Treatment options, although they are either unproven or not studied, are offered as an alternative to routine dose adjustments for LRs. Education remains the foundation of physician-patient communication concerning LRs.

Entities:  

Mesh:

Year:  2011        PMID: 21170613     DOI: 10.1007/s11882-010-0172-5

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  26 in total

1.  Local reactions during allergen immunotherapy do not require dose adjustment.

Authors:  M S Tankersley; K K Butler; W K Butler; D W Goetz
Journal:  J Allergy Clin Immunol       Date:  2000-11       Impact factor: 10.793

Review 2.  Allergen immunotherapy: a practice parameter second update.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  2007-09       Impact factor: 10.793

3.  [WHO position paper. "Allergen immunotherapy: therapeutic vaccines for allergic diseases"].

Authors: 
Journal:  Arerugi       Date:  1998-07

4.  Patient dropouts before completion of optimal dose, multiple allergen immunotherapy.

Authors:  B J Rhodes
Journal:  Ann Allergy Asthma Immunol       Date:  1999-03       Impact factor: 6.347

5.  Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study.

Authors:  L Nielsen; C R Johnsen; H Mosbech; L K Poulsen; H J Malling
Journal:  J Allergy Clin Immunol       Date:  1996-06       Impact factor: 10.793

6.  The GILL study: glycerin-induced local reactions in immunotherapy.

Authors:  Christopher W Calabria; Christopher A Coop; Michael S Tankersley
Journal:  J Allergy Clin Immunol       Date:  2007-10-24       Impact factor: 10.793

7.  Premedication with montelukast reduces local reactions of allergen immunotherapy.

Authors:  Stefan Wöhrl; Simon Gamper; Wolfgang Hemmer; Georg Heinze; Georg Stingl; Tamar Kinaciyan
Journal:  Int Arch Allergy Immunol       Date:  2007-05-25       Impact factor: 2.749

8.  Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.

Authors:  Graham Roberts; Catriona Hurley; Victor Turcanu; Gideon Lack
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

9.  Natural history of large local reactions from stinging insects.

Authors:  P M Mauriello; S H Barde; J W Georgitis; R E Reisman
Journal:  J Allergy Clin Immunol       Date:  1984-10       Impact factor: 10.793

10.  The safety of immunotherapy during pregnancy.

Authors:  W J Metzger; E Turner; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1978-04       Impact factor: 10.793

View more
  1 in total

1.  Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases.

Authors:  Yaqi Yang; Dongxia Ma; Nan Huang; Wenjing Li; Qing Jiang; Yin Wang; Xiaolong Wang; Lin Yang; Rongfei Zhu
Journal:  Ital J Pediatr       Date:  2021-04-23       Impact factor: 2.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.